How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Intensive Care Bed Market
- By Bed Type: Standard ICU Beds, Neonatal ICU Beds, Pediatric ICU Beds, Bariatric ICU Beds, Neurosurgical ICU Beds
- By Mobility Feature: Fixed ICU Beds, Mobile ICU Beds
- By Functionality: Manual ICU Beds, Semi-Electric ICU Beds, Fully Electric ICU Beds
- By Application: Hospital ICU, Ambulatory Surgical Centers, Long-term Care Facilities
- By End User: Hospitals, Specialty Clinics, Home Healthcare
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Standard ICU Beds leads By Bed Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.172 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the Intensive Care Bed Market report
A complete, evidence-based study - 12 chapters and 119 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Bed Type 5
Mobility Feature 2
Functionality 3
Application 3
End User 3
Companies profiled
Hill-Rom Holdings
Inc. (a Baxter International company)
Stryker Corporation
Getinge AB
Arjo AB
Drägerwerk AG & Co. KGaA
Medline Industries Inc.
Invacare Corporation
Joerns Healthcare LLC
Linet Group SE
Span-America Medical Systems Inc.
Gendron Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Hill-Rom Holdings
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Inc. (a Baxter International company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Getinge AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Arjo AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Drägerwerk AG & Co. KGaA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Medline Industries Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Invacare Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Joerns Healthcare LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Linet Group SE
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Span-America Medical Systems Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Gendron Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Ferno-Washington Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Paramount Bed Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Malvestio S.p.A.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,377M by 2033 · 8.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Standard ICU Beds53.1
- Neonatal ICU Beds10.2
- Pediatric ICU Beds15.4
- Bariatric ICU Beds10.7
- Neurosurgical ICU Beds10.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,244M → $2,651M · 9.9%
Europe$867.1M → $1,638M · 8.3%
Asia Pacific$791.7M → $1,388M · 7.3%
Latin America$490.1M → $921.4M · 8.2%
Middle East and Africa$377.0M → $668.3M · 7.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.722026
8.712027
8.732028
8.742029
8.762030
8.762031
8.782032
8.782033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Hill-Rom Holdings30.6
- Inc. (a Baxter International company)14.7
- Stryker Corporation4.4
- Getinge AB4.4
- Arjo AB13.0
- Drägerwerk AG & Co. KGaA4.8
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Bed Type24.2%
Mobility Feature19.3%
Functionality16.9%
Application20.8%
End User18.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.5
- Europe22.5
- Asia Pacific19.1
- Latin America12.7
- Middle East and Africa9.2
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Hill-Rom Holdings | 91 | 93 | 91 | 95 | 82 | 86 | 90 |
| Inc. (a Baxter International company) | 74 | 84 | 76 | 84 | 71 | 73 | 77 |
| Stryker Corporation | 65 | 66 | 67 | 72 | 68 | 83 | 70 |
| Getinge AB | 65 | 75 | 72 | 82 | 76 | 73 | 74 |
| Arjo AB | 69 | 56 | 66 | 67 | 73 | 70 | 67 |
| Drägerwerk AG & Co. KGaA | 52 | 48 | 66 | 47 | 47 | 49 | 52 |
| Medline Industries Inc. | 52 | 63 | 49 | 54 | 58 | 57 | 56 |
| Invacare Corporation | 43 | 45 | 51 | 60 | 36 | 38 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Hill-Rom Holdings
- Inc. (a Baxter International company)
- Stryker Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Hill-Rom Holdings | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Inc. (a Baxter International company) | ◐ | ◐ | ◐ | ◐ | − | ✓ |
| Stryker Corporation | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Getinge AB | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Arjo AB | ✓ | − | − | − | ✓ | − |
| Drägerwerk AG & Co. KGaA | − | − | ◐ | − | ◐ | − |
| Medline Industries Inc. | − | ◐ | ◐ | ◐ | − | ◐ |
| Invacare Corporation | ◐ | ◐ | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Hill-Rom Holdings90
2Inc. (a Baxter International company)77
3Getinge AB74
4Stryker Corporation70
5Arjo AB67
6Medline Industries Inc.56
7Drägerwerk AG & Co. KGaA52
8Invacare Corporation46
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Hill-Rom Holdings
Challenger4
Strong scale, closing on the leaders.
Inc. (a Baxter International company)Stryker CorporationGetinge ABArjo AB
Niche3
Specialists in a single segment or region.
Drägerwerk AG & Co. KGaAMedline Industries Inc.Invacare Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Bed Type in North America, then scale across Intensive Care Bed Market — a $100M beachhead inside a $1.57B market.
Beachhead (SOM)$100Mobtainable near-term
Serviceable (SAM)$626Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Standard ICU Beds
Best fit — highest urgency & budget in Bed Type.
Economic buyer77 fit
Neonatal ICU Beds
Strong fit — clear ROI and a fast path to value.
End user70 fit
Pediatric ICU Beds
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Bed Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Mobility Feature & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Functionality
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel28%
Digital / self-serve23%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Bed Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Intensive Care Bed Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified26%
Evaluation11%
Closed-won6%
$8.1KCAC
$36KLTV
4.5:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Intensive Care Bed Market is a durable-growth opportunity — $4.98B by 2033, compounding at 8.5%.
TAM · 2025$2.60Btoday
TAM · 2033$4.98Bforecast
CAGR8.5%2027–2033
Cumulative$33.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.98BTotal addressable market
SAM$2.02BServiceable available market
SOM$326MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.5% CAGR
Demand compounds through 2033, outpacing GDP across Bed Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Bed Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.98BLarge & growingTAM by 2033 at 8.5% CAGR
$2.02BServiceable nowreachable with today’s model
$326MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.89BBear5.5% CAGR
$4.98BBase8.5% CAGR
$6.38BBull11.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Mobility Feature optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Intensive Care Bed Market — a $4.49B market by 2033. Plan: grow share from 7.4% to 12.2%.
Market size · 2033$4.49Btotal addressable
Market CAGR5.2%2027–2033
Target share12.2%from 7.4% today
Revenue ambition$548Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.4% | 12.2% | Ahead |
| Revenue | $348M | $548M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 38.0% | 42.1% | Behind |
| Customer retention | 91.8% | 95.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Bed Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Mobility Feature capability
A defensible second engine — invest in Mobility Feature to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Bed Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Mobility Feature
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $80M capacity & capability investment
- Greenlight bolt-on M&A in Mobility Feature
- Authorise North America expansion plan
- Fund R&D program for Bed Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Intensive Care Bed Market conversation — a $8.20B market you can size, segment and defend in minutes.
Market size · 2033$8.20Btotal opportunity
Growth10.3%CAGR to 2033
Addressable buyers1,197+accounts in scope
Typical ROI6.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Bed Type
Goal Grow share in Bed Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.5×return on cost, year one
< 3 mopayback period
$50K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Hill-Rom HoldingsInc. (a Baxter International company)Stryker CorporationGetinge ABArjo ABDrägerwerk AG & Co. KGaAMedline Industries Inc.Invacare Corporation+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Intensive Care Bed Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Intensive Care Bed Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Intensive Care Products Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportInteractive Flat Panel Displays Software for Education Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportInteractive Flat Panel for Education Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportInteractive Flat-Panel Display (IFPD) Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportInteractive Graphic Display Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportInteractive Patient Care Systems (IPC) Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportInteractive Projection System Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportInteractive Projector Market
Market size, share, segmentation and regional forecast.
$326M market · 2025 base year
View reportInteractive Set Top Box Market
Market size, share, segmentation and regional forecast.
$679M market · 2025 base year
View reportInteractive Smart Desks Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportInteractive Smart Tablet Market
Market size, share, segmentation and regional forecast.
$475M market · 2025 base year
View reportInteractive Table for Digital POS Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.